AI Agent Data Analysis Platform Edelbyte Completes $70M Seed and Series A Funding

iconPANews
Share
AI summary iconSummary
Edelbyte, an AI agent data analysis platform, has raised $70 million in seed and Series A funding, according to the Fear and Greed Index of market sentiment. Sequoia Capital and Quiet Capital led the round, with Greenoaks and Swish Ventures also participating. The company, founded in 2025 and headquartered in Tel Aviv and San Francisco, leverages the experience of its four co-founders from Microsoft’s Azure Kusto team. CEO Avner Aharoni leads the development of a unified engine and query federation architecture to manage high-volume AI agent queries. Funding levels in the sector remain robust as demand for AI infrastructure continues to grow.

PANews, November 11: According to Forbes, data analytics platform Edelbyte has ended its stealth mode, disclosing the completion of a $70 million seed and Series A funding round. The round was led by Sequoia Capital and Quiet Capital, with participation from Greenoaks and Swish Ventures. Founded in 2025 and headquartered in Tel Aviv and San Francisco, Edelbyte employs a unified engine and federated query architecture to handle the high volume of queries generated by AI agents. All four co-founders previously spent over a decade at Microsoft, contributing to the development of Azure Kusto (Azure Data Explorer); the CEO is Avner Aharoni.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.